deltatrials

Schizoaffective disorder Trials in Los Angeles, United States

Conditions / Schizoaffective disorder / Los Angeles, United States

Schizoaffective disorder has been the subject of sustained clinical investigation across multiple research sites.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID Title Status Phase
NCT00330863 Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy COMPLETED PHASE4
NCT00222235 Adjunctive Treatment for Decreasing Symptoms of Schizophrenia COMPLETED PHASE2/PHASE3
NCT05204407 Luteolin for the Treatment of People With Schizophrenia COMPLETED
NCT02267070 Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode COMPLETED NA
NCT00641745 Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia COMPLETED PHASE3
NCT05208190 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial RECRUITING PHASE4
NCT00206102 A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder COMPLETED PHASE4
NCT00498550 Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual COMPLETED PHASE4
NCT05890183 Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode RECRUITING NA
NCT05658510 Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) COMPLETED PHASE3

Related Pages